Jon Napitupulu

Sanofi closed 2025 with a strong fourth quarter: net sales rose 13.3% at constant exchange rates to €11.3 billion...

Roche closed 2025 with 7% group sales growth at constant exchange rates, powered by a 9% rise in Pharmaceuticals...

Evestia Clinical has acquired ICRC-Weyer, a long-standing Berlin-based CRO and scientific consultancy, adding specialist capabilities in biostatistics, data management,...

Boehringer Ingelheim has licensed global rights, excluding Greater China, to SIM0709 from Simcere in a deal tied to up...

Nurix Therapeutics has initiated Daybreak, a pivotal, single‑arm phase 2 study of its oral BTK degrader bexobrutideg in relapsed/refractory...

PDS Biotechnology reported early clinical data from an NCI-led study showing its investigational tumor-targeted IL-12 immunocytokine, PDS01ADC, combined with...

Mabtech and Sai Life Sciences have formed a collaboration that designates Sai’s Boston site as a co-marketed U.S. execution...

Sanofi closed 2025 with a sharp acceleration in Q4 performance and set a higher bar for 2026. Fourth-quarter sales...

Roche posted a 7% increase in 2025 Group sales at constant exchange rates, with Pharmaceuticals up 9% and Diagnostics...

Roche posted a stronger-than-expected 2025 finish, with group sales up 7% at constant exchange rates to CHF 61.5 billion,...